130 related articles for article (PubMed ID: 3046042)
1. Subunit B of factor XIII is present in bovine platelets.
Takagi J; Kasahara K; Sekiya F; Inada Y; Saito Y
Thromb Res; 1988 Jun; 50(6):767-74. PubMed ID: 3046042
[TBL] [Abstract][Full Text] [Related]
2. "A" subunit of factor XIII is present on bovine platelet membrane and mediates collagen-induced platelet activation.
Kasahara K; Takagi J; Sekiya F; Inada Y; Saito Y
Thromb Res; 1988 Apr; 50(2):253-63. PubMed ID: 2839910
[TBL] [Abstract][Full Text] [Related]
3. Enzyme-linked immunosorbent assay for the determination of blood coagulation factor XIII A-subunit in plasma and in cell lysates.
Katona E E; Ajzner E; Tóth K; Kárpáti L; Muszbek L
J Immunol Methods; 2001 Dec; 258(1-2):127-35. PubMed ID: 11684129
[TBL] [Abstract][Full Text] [Related]
4. Binding of plasma factor XIII to thrombin-receptor activated human platelets.
Nagy B; Simon Z; Bagoly Z; Muszbek L; Kappelmayer J
Thromb Haemost; 2009 Jul; 102(1):83-9. PubMed ID: 19572072
[TBL] [Abstract][Full Text] [Related]
5. Assessment of Factor XIII.
Muszbek L; Katona É; Kerényi A
Methods Mol Biol; 2017; 1646():277-293. PubMed ID: 28804836
[TBL] [Abstract][Full Text] [Related]
6. Factor XIII is not involved in human platelet-collagen interaction.
Aihara M; Sawada Y; Takami H; Kariya K; Kudo I; Kimura A; Yoshida Y
Tohoku J Exp Med; 1989 Sep; 159(1):37-44. PubMed ID: 2815074
[TBL] [Abstract][Full Text] [Related]
7. Factor XIII deficiency: complete phenotypic characterization of two cases with novel causative mutations.
Katona É; Muszbek L; Devreese K; Kovács KB; Bereczky Z; Jonkers M; Shemirani AH; Mondelaers V; Ermens AA
Haemophilia; 2014 Jan; 20(1):114-20. PubMed ID: 24118344
[TBL] [Abstract][Full Text] [Related]
8. Factor XIII: a marker of mono- and megakaryocytopoiesis.
Adány R; Kiss A; Muszbek L
Br J Haematol; 1987 Oct; 67(2):167-72. PubMed ID: 3314976
[TBL] [Abstract][Full Text] [Related]
9. Platelets but not monocytes contribute to the plasma levels of factor XIII subunit A in patients undergoing autologous peripheral blood stem cell transplantation.
Inbal A; Muszbek L; Lubetsky A; Katona E; Levi I; Kárpáti L; Nagler A
Blood Coagul Fibrinolysis; 2004 Apr; 15(3):249-53. PubMed ID: 15060422
[TBL] [Abstract][Full Text] [Related]
10. An international collaborative study to assign value for Total Factor XIII-B Subunit Antigen to the WHO 1st International Standard for Factor XIII Plasma, (02/206): Communication from the ISTH SSC Subcommittee on Factor XIII and Fibrinogen.
Raut S; Katona É; Riches-Duit A; Coxon C; Muszbek L; Schroeder V; Rigsby P
J Thromb Haemost; 2022 Feb; 20(2):525-531. PubMed ID: 34784091
[TBL] [Abstract][Full Text] [Related]
11. A coagulation factor becomes useful in the study of acute leukemias: studies with blood coagulation factor XIII.
Kiss F; Simon A; Csáthy L; Hevessy Z; Katona E; Kiss C; Kappelmayer J
Cytometry A; 2008 Mar; 73(3):194-201. PubMed ID: 18000871
[TBL] [Abstract][Full Text] [Related]
12. Severe bleeding complications caused by an autoantibody against the B subunit of plasma factor XIII: a novel form of acquired factor XIII deficiency.
Ajzner E; Schlammadinger A; Kerényi A; Bereczky Z; Katona E; Haramura G; Boda Z; Muszbek L
Blood; 2009 Jan; 113(3):723-5. PubMed ID: 18955560
[TBL] [Abstract][Full Text] [Related]
13. Distribution of fibrinogen, and platelet factors 4 and XIII in subcellular fractions of human platelets.
Broekman MJ; Handin RI; Cohen P
Br J Haematol; 1975 Sep; 31(1):51-5. PubMed ID: 1212435
[TBL] [Abstract][Full Text] [Related]
14. Non-autoimmune combined factor XIII A and B subunit deficiencies in rheumatoid arthritis patients treated with anti-interleukin-6 receptor monoclonal antibody (tocilizumab).
Souri M; Mokuda S; Inanami H; Osaki T; Takasugi K; Ichinose A
Thromb Res; 2016 Apr; 140():100-105. PubMed ID: 26938156
[TBL] [Abstract][Full Text] [Related]
15. Leukemic lymphoblasts, a novel expression site of coagulation factor XIII subunit A.
Kiss F; Hevessy Z; Veszprémi A; Katona E; Kiss C; Vereb G; Muszbek L; Kappelmayer JN
Thromb Haemost; 2006 Aug; 96(2):176-82. PubMed ID: 16894461
[TBL] [Abstract][Full Text] [Related]
16. Epitope analysis of human monoclonal antibodies from a patient with autoimmune factor XIII deficiency reveals their inhibitory mechanisms.
Osaki T; Souri M; Ozawa T; Muraguchi A; Ichinose A
FEBS Lett; 2023 May; 597(9):1275-1289. PubMed ID: 36876994
[TBL] [Abstract][Full Text] [Related]
17. Factor XIII mediates adhesion of platelets to endothelial cells through alpha(v)beta(3) and glycoprotein IIb/IIIa integrins.
Dardik R; Shenkman B; Tamarin I; Eskaraev R; Harsfalvi J; Varon D; Inbal A
Thromb Res; 2002 Feb; 105(4):317-23. PubMed ID: 12031826
[TBL] [Abstract][Full Text] [Related]
18. Novel aspects of blood coagulation factor XIII. I. Structure, distribution, activation, and function.
Muszbek L; Adány R; Mikkola H
Crit Rev Clin Lab Sci; 1996; 33(5):357-421. PubMed ID: 8922891
[TBL] [Abstract][Full Text] [Related]
19. The difference between platelet and plasma FXIII used to study the mechanism of platelet microvesicle formation.
Holme PA; Brosstad F; Solum NO
Thromb Haemost; 1993 Oct; 70(4):681-6. PubMed ID: 8115996
[TBL] [Abstract][Full Text] [Related]
20. Role of blood coagulation factor XIII in patients with acute pulmonary embolism. Correlation of factor XIII antigen levels with pulmonary occlusion rate, fibrinogen, D-dimer, and clot firmness.
Kucher N; Schroeder V; Kohler HP
Thromb Haemost; 2003 Sep; 90(3):434-8. PubMed ID: 12958612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
